Parkinson’s Disease Treatment Market - By Therapeutic Class (Dopamine Precursors, Monoamine Oxidase B Inhibitors, Catechol-O-Methyl Transferase Inhibitors, Carbidopa/Levodopa, Dopamine Agonists, and Other Therapeutic Classes), By Medical Devices (Deep Brain Stimulation Devices and Carbidopa/Levodopa Enteral Suspension Delivery Devices), By Patient Care Setting (Clinics and Hospitals), By Distribution Channel (Online Pharmacies, Retail Pharmacies, Drug Stores, and Hospital Pharmacies), And By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026
Published Date: 22-Sep-2020Pharmaceutical
Category: Report Format : PDF
Report Code: ZMR-2854
Status : Published
Global Parkinson’s Disease Treatment market, which is projected at 8.38 (USD Billion) by 2026, is slated to register a CAGR of nearly 7.5% over 2020-2026.